Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

835 ARTÍCULOS , VIENDO DEL 31 AL 45

Molecular Mechanisms in Pentanucleotide Repeat Diseases

Loureiro JR, Castro AF, Figueiredo AS, Silveira I.

Cells. 2022 Jan 8;11(2):205. doi: 10.3390/cells11020205.

Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling

Grekhnev DA, Kaznacheyeva EV, Vigont VA.

Int J Mol Sci. 2022 Jan 6;23(2):624. doi: 10.3390/ijms23020624.

Achilles swelling and ataxia in an adolescent: A case report of cerebrotendinous xanthomatosis

Sahli H, Mandour JE, Boularab J, En-Nafaa I, Fenni JE, Hommadi A.

Radiol Case Rep. 2022 Jan 13;17(3):898-901. doi: 10.1016/j.radcr.2021.12.043. eCollection 2022 Mar.

Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial

Coarelli G, Heinzmann A, Ewenczyk C, Fischer C, Chupin M, Monin ML, Hurmic H, Calvas F, Calvas P, Goizet C, Thobois S, Anheim M, Nguyen K, Devos D, Verny C, Ricigliano VAG, Mangin JF, Brice A, Tezenas du Montcel S, Durr A.

Lancet Neurol. 2022 Mar;21(3):225-233. doi: 10.1016/S1474-4422(21)00457-9. Epub 2022 Jan 18.

Real-Life Turning Movements Capture Subtle Longitudinal and Preataxic Changes in Cerebellar Ataxia

Thierfelder A, Seemann J, John N, Harmuth F, Giese M, Schüle R, Schöls L, Timmann D, Synofzik M, Ilg W.

Mov Disord. 2022 May;37(5):1047-1058. doi: 10.1002/mds.28930. Epub 2022 Jan 24.

Gillespie syndrome: An atypical form and review of the literature

Nabih O, Hamdani H, ELMaaloum L, Allali B, ELkettani A.

Ann Med Surg (Lond). 2022 Jan 8;74:103244. doi: 10.1016/j.amsu.2022.103244. eCollection 2022 Feb.

Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy

Madaan P, Behl T, Sehgal A, Singh S, Sharma N, Yadav S, Kaur S, Bhatia S, Al-Harrasi A, Abdellatif AAH, Ashraf GM, Abdel-Daim MM, Dailah HG, Anwer MK, Bungau S.

Neurotox Res. 2022 Apr;40(2):646-669. doi: 10.1007/s12640-022-00477-8. Epub 2022 Jan 26.

Current and emerging treatment modalities for spinocerebellar ataxias

Ghanekar SD, Kuo SH, Staffetti JS, Zesiewicz TA.

Expert Rev Neurother. 2022 Feb;22(2):101-114. doi: 10.1080/14737175.2022.2029703. Epub 2022 Feb 10.

Gabapentinoid Use in Perioperative Care and Current Controversies

Patel AS, Abrecht CR, Urman RD.

Curr Pain Headache Rep. 2022 Feb;26(2):139-144. doi: 10.1007/s11916-022-01012-2. Epub 2022 Jan 27.

Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies

Dalakas MC.

Neurotherapeutics. 2022 Apr;19(3):832-847. doi: 10.1007/s13311-022-01188-w. Epub 2022 Jan 27.

Coexistence of ataxia‑telangiectasia syndrome and idiopathic CD4 lymphopenia: diagnostic difficulties in a complex immunodeficiency case report

Wawrzycka-Adamczyk K, Matyja-Bednarczyk A, Giza A, Chmura Ł, Kosałka-Węgiel J, Bazan-Socha S.

Pol Arch Intern Med. 2022 May 30;132(5):16202. doi: 10.20452/pamw.16202. Epub 2022 Jan 28.

Early-onset Parkinson's disease with atypical molecular imaging abnormalities in a patient carrying the de novo PRKCG mutation

Chen Y, Liu P, Cen Z, Liao Y, Lin Z, Luo W.

Parkinsonism Relat Disord. 2022 Feb;95:100-102. doi: 10.1016/j.parkreldis.2022.01.020. Epub 2022 Jan 22.

Cerebellar Bottom of Fissure Hyperintensities in MT-ATP6-Associated Ataxia

Roeben B, Bültmann E, Stendel C, Synofzik M.

Ann Neurol. 2022 Mar;91(3):438-440. doi: 10.1002/ana.26311. Epub 2022 Feb 11.

Autosomal recessive spinocerebellar ataxia type 4 with a VPS13D mutation: A case report

Huang X, Fan DS.

World J Clin Cases. 2022 Jan 14;10(2):703-708. doi: 10.12998/wjcc.v10.i2.703.

Child with ataxia and red eyes

Ganai S, Chakraborty U, Chandra A, Sengupta P, Vardhan H, Das S.

Postgrad Med J. 2022 Feb 1;98(e1):e67. doi: 10.1136/postgradmedj-2021-140955.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias